RIVA-DM: Effectiveness and Safety of Rivaroxaban vs. Warfarin in Nonvalvular Atrial Fibrillation and Diabetes Mellitus: Analysis of Electronic Health Record Data

First published 20/08/2020

Last updated 02/07/2024

EU PAS number:

EUPAS36634

Study

Finalised

Documents

Study protocol

Initial protocol

21449_Study Protocol_V1.0_2020-08-19_Redacted

English (679.75 KB - PDF)View document

Updated protocol

21449_Study Protocol_V2.0_2020-11-09_Redacted

First published: 22/02/2024

English (1.14 MB - PDF)View document

Study results

21449_EU PAS Abstract_Redacted_V1.0_2021-11-05

English (542.81 KB - PDF)View document

Study report

21449_Study Report_Redacted_V1.0_2021-11-05

English (867.86 KB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs